BCTXZ Stock Summary and Trading Ideas (Briacell Therapeutics Corp. - Warrant | NASDAQ:BCTXZ)

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Briacell Therapeutics Corp. - Warrant trades on the NASDAQ stock market under the symbol BCTXZ.

As of October 26, 2026, BCTXZ stock price declined to $0.12 with 2,000 million shares trading.

BCTXZ has a beta of 2.77, meaning it tends to be more sensitive to market movements. BCTXZ has a correlation of 0.05 to the broad based SPY ETF.

BCTXZ has a market cap of $0.00. This is considered a Sub-Micro Cap stock.

BCTXZ has underperformed the market in the last year with a price return of -72.9% while the SPY ETF gained +15.1%. However, in the short term, BCTXZ had mixed performance relative to the market. It has outperformed in the last 3 months, returning +22.7% vs +3.9% return in SPY. But in the last 2 weeks, BCTXZ shares have been beat by the market, returning -42.2% compared to an SPY return of -1.7%.

BCTXZ support price is $.11 and resistance is $.17 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BCTXZ shares will trade within this expected range on the day.